May 30, 2023 09:26AM
May 30, 2023 09:25AM
May 15, 2023 05:17PM
May 15, 2023 05:15PM
Apr 5, 2023 08:05AM
Apr 5, 2023 08:00AM
Mar 28, 2023 08:02AM 9 Meters Biopharma (NMTR) Provides Business Update, Reports Q4
Mar 28, 2023 08:00AM
Mar 15, 2023 04:05PM
Mar 14, 2023 08:04AM
Mar 14, 2023 08:00AM
Nov 29, 2022 08:00AM
Nov 8, 2022 08:00AM
Sep 26, 2022 05:44PM After-Hours Movers: Nautilus Gains on Strategic Review
Sep 26, 2022 04:07PM
Sep 26, 2022 04:05PM
Aug 15, 2022 07:00AM
Jul 6, 2022 09:00AM
Jun 30, 2022 07:00AM
Jun 21, 2022 08:02AM
Jun 21, 2022 08:00AM 9 Meters Biopharma Announces Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation
May 16, 2022 07:00AM
Apr 20, 2022 09:02AM
Apr 20, 2022 09:00AM
Mar 23, 2022 07:04AM
Mar 23, 2022 07:00AM
Feb 28, 2022 04:16PM
Feb 28, 2022 04:15PM 9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
Oct 26, 2021 07:36AM
Oct 26, 2021 07:30AM
Oct 4, 2021 07:32AM
Oct 4, 2021 07:30AM
Aug 16, 2021 08:19AM
Aug 16, 2021 08:15AM
Aug 12, 2021 08:30AM 9 Meters Biopharma Provides Business Update and Reports Financial Results for the Second Quarter 2021
Jun 14, 2021 07:30AM
May 26, 2021 08:33AM
May 26, 2021 08:30AM
May 17, 2021 07:33AM
May 17, 2021 07:30AM
May 13, 2021 07:30AM
Apr 7, 2021 09:29AM Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Mar 22, 2021 04:00PM
Dec 11, 2020 09:30AM
Dec 9, 2020 07:38AM
Dec 9, 2020 07:30AM
Dec 7, 2020 07:32AM 9 Meters Biopharma (NMTR) Announces Positive Topline Data for NM-002, a Proprietary Long-Acting GLP-1, in Phase 1b/2a Trial for Short Bowel Syndrome
Dec 7, 2020 07:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All